Adagio Therapeutics’ David Hering is shedding his interim status—as well as his chief operating officer title—stepping into the role of permanent CEO more than four months after the infectious disease ...
Adagio Therapeutics, attempting to bring COVID-19 treatments to market after raising a massive haul of capital during the pandemic, will have to go soul searching as its CEO is out the door with no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback